Novo Nordisk Aktie
41,25
EUR
-2,68
EUR
-6,09
%
42,45
EUR
-1,51
EUR
-3,44
%
Werbung
Novo Nordisk Aktie Analyse
10.08.20 | Novo Nordisk Outperform | Credit Suisse Group | |
07.08.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
07.08.20 | Novo Nordisk Outperform | Bernstein Research | |
07.08.20 | Novo Nordisk Outperform | Credit Suisse Group | |
06.08.20 | Novo Nordisk Neutral | UBS AG | |
06.08.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
06.08.20 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
06.08.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
Werbung
|
|||
20.07.20 | Novo Nordisk Neutral | UBS AG | |
16.07.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
16.07.20 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
22.06.20 | Novo Nordisk Neutral | Oddo BHF | |
18.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
16.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
15.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
12.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
12.06.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
11.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
05.06.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
05.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
05.06.20 | Novo Nordisk Neutral | UBS AG | |
21.05.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
14.05.20 | Novo Nordisk Neutral | UBS AG | |
14.05.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
13.05.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
13.05.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
11.05.20 | Novo Nordisk Neutral | UBS AG | |
07.05.20 | Novo Nordisk overweight | Barclays Capital | |
07.05.20 | Novo Nordisk Outperform | Credit Suisse Group | |
06.05.20 | Novo Nordisk buy | UBS AG | |
06.05.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
06.05.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
29.04.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
17.04.20 | Novo Nordisk buy | UBS AG | |
15.04.20 | Novo Nordisk buy | UBS AG | |
15.04.20 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
15.04.20 | Novo Nordisk Outperform | Bernstein Research | |
14.04.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
09.04.20 | Novo Nordisk overweight | Barclays Capital | |
07.04.20 | Novo Nordisk Hold | Deutsche Bank AG | |
07.04.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
06.04.20 | Novo Nordisk Hold | Deutsche Bank AG | |
31.03.20 | Novo Nordisk Neutral | Oddo BHF | |
24.03.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
23.03.20 | Novo Nordisk buy | UBS AG | |
18.03.20 | Novo Nordisk Outperform | Bernstein Research | |
17.03.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
17.03.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
17.03.20 | Novo Nordisk overweight | Barclays Capital | |
02.03.20 | Novo Nordisk overweight | Barclays Capital |
Werbung
Werbung